Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:DG 16:0_16:2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003645 AN005984 Targeting the c-MYC/ELOVL6 Pathway Alters Cell Membrane Mechanics and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer Cultured cells Human Cancer Universidad Francisco de Vitoria - Hospital 12 de Octubre LC-MS
ST002334 AN003810 Phospholipase D3 impact on the endolysosomal lipidome Cultured cells Human Alzheimers disease VIB-KU Leuven LC-MS
ST001794 AN002913 Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples Jejunum Human University of California, Davis LC-MS
ST001687 AN002754 Non-transformed cells respond to fat by inducing glucose metabolism Liver Mouse VIB-KU Leuven Center for Cancer Biology LC-MS
ST001267 AN002104 Mass spectrometry-based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism Tongue Human Cancer University of Helsinki MS(Dir. Inf.)
  logo